SHARPE·IQStart free
Menu
TodayResearchEarningsToolsPricingSign in
SBC reported Third quarter of fiscal year 2026 results. The price and volatility reaction is pending.
SBCearnings

Earnings reactions, page 2

SBC Medical Group Holdings Incorporated (SBC) Q3 FY2026 earnings

November 13, 2026 · SharpeIQ Research Desk

Reported results

  • Total revenues were $59 million, up 35% year-over-year.
  • Income from operations was $26 million, up 66% year-over-year, with an operating margin of 45%.
  • Net income attributable to SBC Medical was $16 million, up 22% year-over-year, with a net income margin of 27%.
  • Adjusted EBITDA was $28 million, up 66% year-over-year.
  • Adjusted EBITDA margin expanded 9 percentage points year-over-year to 47%.
  • Basic earnings per share (EPS) was $0.15, up 25% year-over-year.

Price and volatility reaction

Source

The figures above come from the earnings release the company filed with the SEC on 2026-11-13 (8-K, Item 2.02). Read the original filing on sec.gov.

See this live in SharpeIQ

IV rank, historical IV and the single-ticker tools. The scanner and AI research are paid plans.

Open IV Rank →